Chromium as a dietary supplement
Chromium is a trace mineral that plays a crucial role in human nutrition, particularly in glucose regulation. It functions as a cofactor for insulin, helping to transport glucose into cells. As a dietary supplement, chromium is primarily proposed for managing diabetes, improving insulin sensitivity, and possibly aiding in weight loss, though research results on these benefits are mixed. Some studies suggest chromium supplementation may enhance blood sugar control in individuals with type 2 diabetes and those with mild blood sugar abnormalities, potentially reducing the risk of heart disease. Other proposed uses of chromium include treatment for acne, depression, and metabolic syndrome, though evidence supporting these claims is limited.
Dietary sources of chromium include brewer's yeast, calf liver, whole grains, and certain beers, but deficiencies are rare and typically occur in individuals receiving intravenous nutrition. Recommended daily intake varies by age and gender. While therapeutic doses for chromium supplements generally range from 200 to 1,000 micrograms, higher doses may pose risks, including potential toxicity and interactions with medications. Individuals considering chromium supplementation should consult healthcare professionals, especially if they have underlying health conditions or are taking other medications.
Chromium as a dietary supplement
DEFINITION: Essential natural substance used as a dietary supplement for specific health benefits.
- PRINCIPAL PROPOSED USES: Diabetes, insulin resistance, abnormal glucose tolerance, heart disease prevention
- OTHER PROPOSED USES: Acne, depression, functional hypoglycemia, high cholesterol, metabolic syndrome (syndrome X), migraine headaches, psoriasis, sports performance enhancement, weight loss
Overview
Chromium is a mineral the body needs in very small amounts, but it plays a significant role in human nutrition. Chromium’s most important function in the body is to help regulate the amount of glucose (sugar) in the blood. Insulin plays a starring role in this fundamental biological process by regulating the movement of glucose from the blood and into cells.
Scientists believe that insulin uses chromium as an assistant (technically, a cofactor) to “unlock the door” to the cell membrane, allowing glucose to enter the cell. In the past, it was believed that to accomplish this, the body first converted chromium into a large chemical called glucose tolerance factor (GTF). Intact GTF was thought to be present in certain foods, such as brewer’s yeast, and for that reason, such products were described as superior sources of chromium. However, subsequent investigation indicated that researchers were actually creating GTF inadvertently during the process of chemical analysis. Scientists now believe that there is no such thing as GTF. Rather, chromium appears to act in concert with a very small protein called low molecular weight chromium-binding substance (LMWCr) to assist insulin’s action. LMWCr does not permanently bind chromium and is not a likely source of chromium in foods.
Based on chromium’s close relationship with insulin, this trace mineral has been studied as a treatment for diabetes. The results have been somewhat positive, and it is likely that chromium supplements can improve blood sugar control in people with diabetes. Chromium also might be helpful for milder abnormalities in blood sugar metabolism. One study suggests that chromium might aid in weight loss, too, but other studies failed to find this effect.
Requirements and Sources
The official US recommendations for daily intake of chromium (in micrograms) are as follows: infants to six months (0.2) and seven to twelve months of age (5.5); children one to three years (11) and four to eight years (15); girls age nine to thirteen years (21) and fourteen to eighteen years (24); boys age nine to thirteen years (25); males age fourteen to fifty years (35); women age nineteen to fifty years (25), men age fifty-one and older (30), women age fifty-one and older (20), pregnant girls (29), pregnant women (30), nursing girls (44) and nursing women (45).
Severe chromium deficiency has been seen only in hospitalized individuals receiving nutrition intravenously. Symptoms include problems with blood sugar control that cannot be corrected by insulin alone. In general, researchers believe chromium deficiency to be relatively rare.
Corticosteroid treatment may cause increased chromium loss in the urine. It is possible that this loss of chromium may contribute to corticosteroid-induced diabetes.
Chromium is found in drinking water, especially hard water, but concentrations vary widely. Many good sources of chromium, such as whole wheat, are depleted of this important mineral during processing. The most concentrated sources of chromium are brewer’s yeast (not nutritional or torula yeast) and calf liver. Two ounces of brewer’s yeast or four ounces of calf liver supply between 50 and 60 micrograms (mcg) of chromium. Other good sources of chromium are whole grains, beer, and cheese. Also, calcium carbonate interferes with the absorption of chromium.
Therapeutic Dosages
The dosage of chromium used in studies ranges from 200 to 1,000 mcg daily, mostly in the form of chromium picolinate. However, there may be potential risks in the higher dosages of chromium. These and all other dosages of chromium cite the amount of the actual chromium ion in the supplement (“elemental chromium”), discounting the weight of the substances, such as picolinate, attached to it.
Chromium supplements are available in several variations, including chromium picolinate, chromium nicotinate, chromium polynicotinate, chromium histidinate, and chromium chloride. Some products state they contain Glucose Tolerance Factor (GTF) chromium, which is a type of active chelated chromium.
![Chromium metal chunk. By de.wikipedia.org/w/index.php?title=Benutzer:Tomihahndorf&action=edit (de.wikipedia.org/wiki/Bild:Chrom_1.jpg) [Public domain], via Wikimedia Commons 94415702-90255.jpg](https://imageserver.ebscohost.com/img/embimages/ers/sp/embedded/94415702-90255.jpg?ephost1=dGJyMNHX8kSepq84xNvgOLCmsE2epq5Srqa4SK6WxWXS)

Therapeutic Uses
Chromium has principally been studied for its possible benefits in improving blood sugar control in people with diabetes. Several studies suggest that people with type 2 diabetes may show some improvement when given appropriate dosages of chromium. One study suggests that chromium may also be useful for diabetes that occurs during pregnancy. Additionally, nondiabetic people with mildly impaired blood sugar control might attain better control of blood sugar with chromium supplementation. Because mild impairment of blood sugar control is believed to increase the risk of heart disease, chromium supplementation might help reduce heart disease rates.
Chromium has been sold as a “fat burner” and is also said to help build muscle tissue. However, most studies evaluating chromium’s ability to promote weight loss have not found benefits. One study failed to find benefit with a combination of chromium and conjugated linoleic acid. Studies evaluating chromium as a performance enhancer or aid to bodybuilding have yielded almost entirely negative results.
Studies on whether chromium can improve cholesterol levels have returned mixed results. However, one study suggests that chromium combined with grape seed extract might have a beneficial effect. Additionally, among people taking beta-blockers, chromium may raise levels of HDL (good) cholesterol.
When depression is characterized by rapid mood changes, excessive sleeping and eating, a sense of leaden paralysis, and extreme sensitivity to negative life events, the condition is called atypical depression. A small (fifteen participants) double-blind, placebo-controlled study found that chromium picolinate might be helpful for this form of depression, but several subsequent studies failed to find statistically significant benefits.
According to some researchers, impaired blood sugar control, high cholesterol, weight gain, and high blood pressure are all part of a larger condition called metabolic syndrome, or syndrome X. Because chromium may be helpful for the first three of these conditions, chromium deficiency has been proposed as the cause of syndrome X. More research is required to confirm these findings.
One study failed to find that chromium picolinate at 200 mcg per day can improve symptoms of polycystic ovaries, which is a common cause of infertility. Chromium has also been proposed as a treatment for acne, migraine headaches, and psoriasis, but there is no real evidence that it works for these conditions.
Scientific Evidence
Diabetes. The evidence regarding use of chromium for type 2 diabetes and other forms of diabetes remains incomplete and inconsistent. In a double-blind, placebo-controlled study, 180 people with type 2 diabetes were given a placebo, 200 mcg of chromium picolinate, or 1,000 mcg of chromium picolinate daily. The results showed that HbA1c values (a measure of long-term blood sugar control) improved significantly after two months in the group receiving 1,000 mcg and in both chromium groups after four months. Fasting glucose (a measure of short-term blood sugar control) was also lower in the group taking the higher dose of chromium.
A double-blind trial of seventy-eight people with type 2 diabetes compared two forms of chromium (brewer’s yeast and chromium chloride) with a placebo. This rather complex crossover study consisted of four eight-week intervals of treatment in random order. The results in the sixty-seven people who completed the study showed that both forms of chromium significantly improved blood sugar control.
Positive results were also seen in three other double-blind, placebo-controlled studies enrolling more than 130 people with type 2 diabetes. However, several other studies have failed to find benefit for people with type 2 diabetes. These contradictory findings suggest that the benefit, if it really exists, is small at best.
A combination of chromium and biotin might be more effective. Following positive results in a small pilot trial, researchers conducted a double-blind study of 447 people with poorly controlled type 2 diabetes. One-half the participants were given a placebo, and the rest were given a combination of 600 mcg chromium (as chromium picolinate) with 2 mg of biotin daily. All participants continued to receive standard oral medications for diabetes. In the ninety-day study period, participants given the chromium-biotin combination showed significantly better glucose regulation than those given a placebo. The relative benefit was clear in levels of fasting glucose and in HgA1c.
One placebo-controlled study of thirty women with pregnancy-related diabetes found that supplementation with chromium (at a dosage of four or eight mcg chromium picolinate for each kilogram of body weight) significantly improved blood sugar control. Also, chromium has shown some promise for treating diabetes caused by corticosteroid treatment.
Improved blood sugar control in people without diabetes. Many people develop impaired responsiveness to insulin (insulin resistance) and mildly abnormal blood sugar levels. A few small, double-blind trials have found that chromium supplementation may be helpful, although two studies found no benefit. Another small, double-blind trial found that chromium improved the body’s response to insulin among overweight people at risk of developing diabetes. There is growing evidence that mildly impaired blood sugar control increases the risk of heart disease, suggesting that chromium supplementation might be useful.
Weight loss. The evidence is mixed on whether chromium is an effective aid for reducing weight or improving body composition (improving the ratio of fatty tissue to lean tissue). In one study, 219 people were given either a placebo or 200 or 400 mcg of chromium picolinate daily. Participants were not advised to follow any particular diet. In seventy-two days, people taking chromium experienced significantly greater weight loss than those not taking chromium, more than two-and-one-half pounds versus about one-quarter pound. People taking chromium gained lean body mass, so the loss of fatty tissue was even more dramatic: more than four pounds versus less than one-half pound. However, a high dropout rate makes the results of this study somewhat unreliable.
However, in another double-blind study by the same researcher, 130 moderately overweight people attempting to lose weight were given either a placebo or 400 mcg of chromium daily. At the end of the trial, no statistically significant differences in weight or body composition were seen between groups. Researchers were able to show benefit only by resorting to fairly complicated statistical maneuvers.
In a third study, forty-four overweight women were given either a placebo or 400 mcg of chromium per day. All participants were placed on an exercise program. Through twelve weeks, no differences were seen between the two groups in terms of body weight, waist circumference, or percentage of body fat. A small double-blind trial of older women undergoing resistance training also failed to find evidence of benefit. Generally negative results also have been seen in other small double-blind trials.
Other studies presented mixed results, leaving chromium's use as a weight loss supplement unknown. When larger studies find positive results and smaller studies do not, it often indicates that the treatment under study is only weakly effective. This may be the case with chromium as a weight-loss treatment. If chromium is effective for weight loss, one small study suggests it may work by influencing the brain and its role in appetite and food cravings.
Heart disease prevention. Insulin resistance and mildly elevated blood sugar levels appear to increase the risk of heart disease. Chromium supplementation might help by improving insulin responsiveness, normalizing blood sugar, and aiding in carbohydrate and lipid metabolism. In support of this, an observational trial found associations between higher chromium intake and reduced risk of heart attack. Building on this finding, many studies found chromium to be a vital mineral in decreasing type 2 diabetes and cardiovascular diseases. A relatively large body of research supports these findings, but other assertions related to chromium’s role in heart disease prevention continue to be explored, such as blood pressure, oxidative stress, and lipid metabolism.
Safety Issues
Although the precise upper limit of safe chromium intake is not known, it is believed that chromium is safe when taken at a dosage of 50 to 200 mcg daily. Side effects appear to be rare. However, chromium is a heavy metal and might conceivably build up and cause problems if taken to excess.
There is one report of kidney, liver, and bone marrow damage in a person who took 1,200 to 2,400 mcg of chromium for several months; in another report, as little as 600 mcg for six weeks was enough to cause damage. Such problems appear to be quite rare, and it is possible that these individuals already had health problems that predisposed them to such a reaction. The risk of chromium toxicity is believed to be higher in people who already have liver or kidney disease.
Nonetheless, based on these reports, it is possible that the dosage of chromium found most effective for people with type 2 diabetes (1,000 mcg daily) might present some health risks. For example, there is some evidence that if chromium is taken in high enough amounts, it may be converted from its original safe form (chromium 3) into a known carcinogen, chromium 6. One should consult a doctor before taking more than 200 mcg of chromium daily.
People who have diabetes and for whom chromium is effective may need to cut down the dosage of any medication taken for diabetes. Again, one should consult a doctor before continuing chromium use.
There are also several concerns about the picolinate form of chromium in particular. Picolinate can alter levels of neurotransmitters. This has led to concern among some experts that chromium picolinate might be harmful for individuals with depression, bipolar disease, or schizophrenia. There also has been one report of a severe skin reaction caused by chromium picolinate.
Finally, there are fairly theoretical and uncertain concerns that chromium picolinate could have adverse effects on deoxyribonucleic acid (DNA). Also, the maximum safe dosage of chromium for women who are pregnant or nursing and for people with severe liver or kidney disease has not been established.
Important Interactions
One may need extra chromium if also taking calcium carbonate supplements like Tums or antacids like esomeprazole (Nexium), lansoprazole (Prevacid), and omeprazole (Prilosec). The chromium supplement and the doses of these substances should not be taken within two hours of each other because the two together may interfere with chromium absorption.
People who are taking corticosteroids may need extra chromium. Also, people who are taking diabetes medications like metformin (Glucophage), glipizide (Glucotrol), chlorpropamide (Diabenese), or insulin should seek medical supervision before taking chromium because the dosages of these drugs might need to be reduced. Chromium supplementation may improve HDL (good) cholesterol levels if the individual is also taking beta-blockers. People taking the synthetic version of thyroxine called Levothyroxine should wait two to three hours before and after taking the medication to take a chromium supplement to avoid inhibited medication absorption.
Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) like Advil and Motrin impact the body’s ability to absorb chromium and may cause adverse side effects.
Individuals with allergies to leather or chromate may also be allergic to chromium. Additionally, individuals with liver or kidney disease should avoid taking chromium supplements.
Bibliography
“Chromium." National Institutes of Health (NIH), 2 June 2022, ods.od.nih.gov/factsheets/Chromium-HealthProfessional. Accessed 20 Aug. 2023.
“Chromium." Harvard School of Public Health, Mar. 2023, www.hsph.harvard.edu/nutritionsource/chromium. Accessed 20 Aug. 2023.
"Chromium." Icahn School of Medicine at Mount Sinai, www.mountsinai.org/health-library/supplement/chromium. Accessed 20 Sept. 2024.
Diaz, M. L., et al. “Chromium Picolinate and Conjugated Linoleic Acid Do Not Synergistically Influence Diet- and Exercise-Induced Changes in Body Composition and Health Indexes in Overweight Women.” Journal of Nutritional Biochemistry, vol. 19, 2008, pp. 61-68.
Docherty, J. P., et al. “A Double-Blind, Placebo-Controlled, Exploratory Trial of Chromium Picolinate in Atypical Depression: Effect on Carbohydrate Craving.” Journal of Psychiatric Practice, vol. 11, 2005, pp. 302-14.
Gossa Al-Saadde, Dhiaa L., et al. “The Role of Chromium Supplementation in Cardiovascular Risk Factors: A Comprehensive Reviews of Putative Molecular Mechanisms.” Heliyon, vol. 9, no. 9, Sept. 2023. doi.org/10.1016/j.heliyon.2023.e19826. Accessed 22 Nov. 2024.
Lucidi, R. S., et al. “Effect of Chromium Supplementation on Insulin Resistance and Ovarian and Menstrual Cyclicity in Women with Polycystic Ovary Syndrome.” Fertility and Sterility, vol. 84, 2005, pp. 1755-57.
Tsang, Catherine, et al. “A Meta-Analysis of the Effect of Chromium Supplementation on Anthropometric Indices of Subjects with Overweight or Obesity.” Clinical Obesity, vol. 9, no. 4, 2019, p. e12313. doi:10.1111/cob.12313.
Yazaki, Y., et al. “A Pilot Study of Chromium Picolinate for Weight Loss.” Journal of Alternative and Complementary Medicine, vol. 16, 2010, pp. 291-299.